 CAMBRIDGE, Mass., March 22, 2022 GLOBE NEWSWIRE -- Pyxis Oncology, Inc. Nasdaq: PYXS, a multi-asset, multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced it will host a conference call and live webcast on Tuesday, March 29, 2022 at 8:00 a.m. ET to discuss recent corporate updates. 